Advertisement

Topics

Companies Related to "Tinzaparin for Primary Treatment and Extended Secondary Prophylaxis of Venous Thromboembolism in Patients With Cancer" [Most Relevant Company Matches] RSS

10:19 EST 19th February 2019 | BioPortfolio

Here are the most relevant search results for "Tinzaparin for Primary Treatment and Extended Secondary Prophylaxis of Venous Thromboembolism in Patients With Cancer" found in our extensive corporate database of over 50,000 company records.

Showing "Tinzaparin Primary Treatment Extended Secondary Prophylaxis Venous Thromboembolism" Companies 1–25 of 4,400+

Relevant

Adamed Sp. z o.o.

Our priority is production of ethical drugs. We are leaders on the market of new generation drugs in many therapeutic groups such as cardiology, psychiatry, pulmonology, gynecology and treatment of urinal tract infections.We invest in research that is set to find effective and innovative original drugs which can be used for the most common diseases of our time, diabetes, venous thromboembolism (VT...


Vnus Medical Technologies

VNUS Medical Technologies, Inc. is dedicated to providing innovative products for treatment of venous disease. Our mission is to help patients look and feel better with safe, fast and more effective treatments for venous disease. VNUS Medical Technologies, founded in 1995, is a public company and world leader in the development and commercialization of products for minimally invasive treatment of...

Sapheon Inc.

Sapheon is an early stage medical device company whose mission is to develop new approaches for the treatment of vascular disease. Our current focus is on developing technology to improve the treatment of venous reflux disease. Sapheon's newly developed vein closure technology responds to the inadequacies of existing venous reflux treatment options by usin...


Venous Disease Coalition

The Venous Disease Coalition (VDC) is an alliance of more than 35 leading health professional societies and patient advocacy groups that have united around a common goal: To improve the survival rates and quality of life for individuals with, or at risk for, venous disease. The VDC plans to develop a national campaign to educate public and health care professionals in the U.S. about venous disease...

InNexus Biotechnology, Inc.

approaches that add secondary properties to monoclonal antibodies (binding is a primary property) and applies to virtually every antibody product currently in development. Adding these secondary properties can increase the potency of antibodies or add new properties such as the ability to penetrate into living cells.As an example, InNexus utilized SAT with a humanized monoclonal antibody, licensed...

Caron Treatment Centers

Caron Treatment Centers is a nationally recognized non-profit provider of alcohol and drug addiction treatment. With more than 50 years in the field, Caron is one of the oldest and largest facilities offering primary, relapse and extended residential treatment for young adults, adults and adolescents, as well as families affected by the disease of addiction. Caron's gender separate and gender spec...

Cortex-Biochem Incorporated

CORTEX BIOCHEM, INC. celebrates its first decade as a primary reagent manufacturer.manufacturer and provider of life science reagents for research and industry including primary and secondary antibodies and magnetizable particles.

Ronald Trahan Associates Inc.

Headquartered in Irvine, Calif., Consilium Associates (www.consiliumassociates.net) offers consulting services in the areas of medical device development, early-stage investment, and primary and secondary market research and analysis. Primary contact: Richard Harbaugh, rharbaugh@consiliumassociates.net, +1-949-733-3436.

InterVene Inc.

InterVene Inc. has developed the first non-implantable, catheter-based, vein valve creation therapy. The product is designed to treat chronic venous insufficiency (CVI) in the deep veins - a severely under-treated disease that causes painful venous stasis ulcers and other debilitating symptoms in millions of Americans annually. For more information, visit www....

Bone Care International Incorporated

Bone Care is a leader in the discovery and development of improved vitamin D-hormone therapies for the treatment of secondary hyperparathyroidism and certain hyperproliferative diseases. D-hormones have a key role in the progression and management of secondary hyperparathyroidism in patient populations with kidney dysfunction, including kidney Dialysis, pre-dialysis, and certain osteoporosis pati...

ReGen therapeutics Plc

The principal activity of ReGen Therapeutics Plc is the development and exploration of Colostrinin as a drug for the prophylaxis and treatment of Alzheimer's disease and other neurological disorders. Colostrinin is a proline-rich polypeptide complex isolated from ovine colostrinin. Colostrum is the mammal's first milk after the birth of an offspring.

D-Pharm Ltd

D-Pharm (http://www.dpharm.com) is a technology-driven biopharmaceutical company focused on the discovery and development of innovative proprietary drugs for the treatment of central nervous system disorders and cancer. D-Pharm is a leader in design and development of lipid-like medicine and its products are new chemical entities (NCEs) derived from its proprietary platform technology. The dru...

HYD Ltd. for Research and Development

HYD Ltd. for Research and Development, a technology based pharmaceutical company was established in 1992 to develop pharmaceuticals and consumer products that utilize a novel proprietary procedure, Deuterium Depletion for the treatment and prophylaxis of various types of cancer and other proliferative and neoplastic diseases. Deuterium Depletion opens new perspectives in cancer treatment and preve...

Tech Collective

The founders of RITEC had as their vision to serve the Rhode Island technology community in its most diverse and broadest context. They believed that by focusing, initially, on one of the key sectors within the technology community, the organization could craft a value package of business support services that could be tested and refined by that sector and then extended and replicated, by phase(s)...

American Qualex Antibodies

Enzyme Labeled, Affinity Purified Second Antibodies and Antiseralabeled primary and secondary antibodies in addition to antibodies for signal transduction.

DAKO

A Danish company with over 1,000 products related to antibodies and antibody technology, including clinical immunohistochemistry, flow cytometry, immunocytochemistry, hybridization, microbiology, primary polyclonal and monoclonals antibodies, secondary an

Jackson ImmunoResearch Laboratories, Inc.

Jackson ImmunoResearch Laboratories, Inc. specializes in the production and conjugation of affinity-purified, secondary antibodies and purified immunoglobulins. Our products are sold primarily to scientists in universities and research institutes throughout the world who are conducting research in the plant, animal, and biomedical sciences.The company is located in rural Pennsylvania, near the Ami...

Stealth Therapeutics Inc.

Stealth Therapeutics was founded in 2006 for the purpose of designing and developing a portfolio of improved venous access devices. The technology is derived from the clinical practice of the company’s founder, Dr. Bradley Glenn. Dr. Glenn, a practicing interventional radiologist with strong interest and experience in venous access devices, guides Ste...

BIOQuebec

BIOQuébec counts more than 200 innovative companies as members and is committed to support the growth and vitality of Quebec’s biotechnology companies. The BIOQuebec members are active in the following sectors:Human and animal health – Research and manufacturing of therapeutic and diagnostic products, vaccines and biological products. Agriculture, bio-food and forestry – Re...

MedDay

MedDay is a privately held biotechnology company developing new drugs for nervous system disorders. The company was founded in 2011 by Frédéric Sedel, MD, PhD (Chief Executive Officer), a leading neurologist and neuroscientist; and Guillaume Brion, MD (Chief Operating Officer) who has 25 years of experience in drug development and clinical research i...

Ginniff Books

Ginniff Books is located on a sheep farm 12 miles west of Iowa City and 2 miles south of Cosgrove; we have 10K shelved books. We welcome browsers by appointment. Most of our business is done on the internet through abebooks.com and our complete listings can be seen there.Our areas of interest are:History of Medicine Monographs, texts and other primary material - especially in Ophthalmology and the...

Evalueserve Inc

Evalueserve's analysts cover a range of industries, including - Banking, Insurance, Hi-Tech, Telecommunications, Pharma & Bio-Tech, Chemicals, Energy, Consumer Goods, Discrete and Process Manufacturing.Our geographic reach is worldwide, including North America, Europe, and Asia. We have performed research in 192 countries. We utilize both primary and secondary sources to conduct our research and a...

Partners in Primary Care

Partners in Primary Care (Partners) is a primary care medical group practice and is part of a larger group of over 60 primary care offices in Florida, South Carolina and Texas operating under the names CAC Florida Medical Centers, Continucare Medical Centers, MetCare and Partners in Primary Care. Partners has a strong emphasis on senior-focused primary car...

ImpediMed Limited

ImpediMed Ltd. is the world leader in the development and distribution of medical devices employing bioimpedance spectroscopy (BIS) technologies for use in the non-invasive clinical assessment and monitoring of fluid status. ImpediMed's primary product range consists of a number of medical devices that aid surgeons, oncologists, therapists and radiation oncologists in the clinical assessment of pa...

Venous Health Systems, Inc.


More From BioPortfolio on "Tinzaparin for Primary Treatment and Extended Secondary Prophylaxis of Venous Thromboembolism in Patients With Cancer"

Advertisement
Quick Search
Advertisement
Advertisement

 

Corporate Database Quicklinks